What Are Peptides? A Beginner’s Research Guide

What Are Peptides?

Peptides are biological molecules made up of amino acids linked together by peptide bonds. The human body uses 20 standard amino acids to build peptides and proteins. When a chain contains between 2 and roughly 50 amino acids, it is classified as a peptide. Chains longer than ~50 amino acids fold into three-dimensional structures and are classified as proteins.

Your body produces thousands of endogenous peptides naturally. Insulin (51 amino acids) sits right at the boundary. Oxytocin (9 amino acids) and vasopressin (9 amino acids) are classic examples of short peptides that drive major physiological effects despite their small size.

Amino Acids, Peptides, and Proteins — What’s the Difference?

Natural vs Synthetic Peptides

Endogenous peptides are produced by your own body. Examples include insulin, glucagon, oxytocin, and endorphins. They regulate metabolism, mood, pain, reproduction, and immune response.

Synthetic peptides are manufactured through solid-phase peptide synthesis (SPPS), a process developed by Bruce Merrifield in 1963 (Nobel Prize, 1984). SPPS allows researchers to build peptide chains with precise amino acid sequences, producing compounds identical to natural peptides or novel sequences designed to target specific receptors. Most research peptides available today are synthetic, produced to ≥98% purity and verified by HPLC analysis.

How Do Peptides Work?

Receptor Binding and Cell Signaling

Peptides function primarily as ligands — molecules that bind to specific receptors on cell surfaces. When a peptide binds its target receptor, it triggers an intracellular signaling cascade: a chain of biochemical events that ultimately changes cell behavior. This is called the lock-and-key model — a specific peptide (key) fits a specific receptor (lock), producing a predictable downstream response.

Unlike small-molecule drugs that often affect many pathways simultaneously, peptides tend to have high receptor specificity, which is why they are of particular interest in pharmacological research. Their selectivity means they can trigger a narrow set of biological effects with fewer off-target interactions.

Key Mechanisms in Peptide Research

• GLP-1 receptor agonism — Peptides like semaglutide and retatrutide bind GLP-1 receptors in the pancreas and brain, regulating insulin secretion and satiety signaling. Compare GLP-1 agents →
• GIP receptor agonism — Glucose-dependent insulinotropic polypeptide receptor activation enhances insulin response and may influence fat metabolism. Tirzepatide is a dual GLP-1/GIP agonist.
• Glucagon receptor agonism — Glucagon receptor activation increases energy expenditure and hepatic glucose output. Retatrutide is the only clinical-stage triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Retatrutide approval status →
• BPC-157 — nitric oxide modulation — Body Protection Compound-157 is a pentadecapeptide isolated from human gastric juice. Published research indicates it modulates nitric oxide (NO) pathways involved in angiogenesis and tissue repair.
• GHK-Cu — copper peptide signaling — Glycyl-L-histidyl-L-lysine bound to copper(II) activates genes involved in collagen synthesis, wound healing, and antioxidant defense. GHK-Cu research data →

Types of Research Peptides

Research peptides span multiple biological domains. The table below categorizes the most studied compounds by their primary research focus, mechanism, and links to our in-depth articles.

For compound-level deep dives, browse the full Research Library — 50+ articles covering clinical data, mechanisms, and approval status.

How Are Peptides Used in Research?

Reconstitution — From Powder to Solution

Most research peptides arrive as a lyophilized (freeze-dried) powder. Before use, this powder must be reconstituted — dissolved in a sterile solvent. The standard solvent is bacteriostatic water (sterile water with 0.9% benzyl alcohol as a preservative).

The process is straightforward: draw the required volume of bacteriostatic water into a syringe, inject it against the vial wall (not directly onto the powder), and gently swirl until fully dissolved. Never shake — agitation can denature the peptide and reduce potency.

For a complete walkthrough with volume calculations, see our Bacteriostatic Water Guide. Use the Reconstitution Calculator to compute exact concentrations.

Storage and Stability

Proper storage is critical for maintaining peptide integrity:

• Lyophilized (unreconstituted): Store at −20°C for long-term stability. Room temperature is acceptable during short transit periods.
• Reconstituted: Refrigerate at 2–8°C. Most reconstituted peptides remain stable for 4–8 weeks under proper refrigeration.
• Avoid: Repeated freeze-thaw cycles, direct sunlight, and contamination from non-sterile handling.

For detailed stability data and degradation timelines, see our Peptide Stability & Storage Guide.

Dosing Protocols in Published Studies

Dosing information for research peptides comes from peer-reviewed clinical trials and published literature. For example, retatrutide was studied in Phase 2 trials at escalating doses from 1 mg to 12 mg administered subcutaneously once weekly. Semaglutide (Wegovy) is dosed at up to 2.4 mg weekly.

We maintain detailed protocol references for key compounds: Retatrutide Dosage Guide | Dosage FAQ | Pen Clicks Chart.

Mixing and Stacking Considerations

Combining multiple peptides in a single research protocol introduces interaction variables. Some peptides are known to be compatible in the same syringe; others may degrade or interfere with each other. Receptor competition, solvent pH, and peptide stability under co-reconstitution all factor in.

Before combining compounds, consult published interaction data. Our Peptide Interactions & Mixing Guide covers known compatibility pairs, contraindications, and best practices for multi-peptide protocols.

Are Peptides Legal?

Regulatory Status by Region

The short answer: it depends on the intended use. Peptides sold for in-vitro laboratory research are legal in most jurisdictions. Peptides sold for human consumption require regulatory approval (FDA in the US, EMA in Europe, TGA in Australia).

The molecule itself is rarely banned. What matters legally is the label claim — “for research use only” versus “for injection” or “for weight loss.” This distinction is critical for suppliers and researchers alike.

In the US, the FDA’s 2023 Category 2 reclassification moved 19 peptides off the compounding pharmacy list, but this did not affect research-use sales. In February 2026, HHS Secretary Kennedy announced plans to reclassify ~14 of those back to Category 1.

For a full country-by-country breakdown including the US, UK, EU, Australia, Canada, and WADA rules, see our dedicated Are Peptides Legal? guide.

UAE and Dubai Regulations

Research peptides for in-vitro laboratory use are available in the UAE. Multiple peptide suppliers operate from Dubai under a “research use only” framework. The UAE Ministry of Health and Prevention (MoHAP) regulates pharmaceutical products but has not issued specific prohibitions on the sale of research-grade peptide compounds.

For UAE-specific availability, delivery, and compliance information, see Research Peptides UAE and Peptide Trends UAE 2026.

How to Verify Peptide Quality

HPLC Purity Testing

High-Performance Liquid Chromatography (HPLC) is the gold standard for peptide purity verification. It separates the target compound from impurities and quantifies the percentage of the desired peptide in the sample. Research-grade peptides should show ≥98% purity on HPLC analysis. Pharmaceutical-grade compounds target ≥99%.

Certificate of Analysis (COA) Verification

A COA is a document issued by the testing laboratory that reports the results of purity and identity testing for a specific batch. A credible COA includes:

• HPLC purity percentage with chromatogram
• Mass spectrometry (MS) confirmation of molecular weight
• Endotoxin testing (LAL test)
• Batch number and manufacturing date
• Name and accreditation of the testing laboratory

Remy Peptides publishes batch-specific COAs from Janoshik Analytical for every product. Browse our COA Library to verify any batch.

Third-Party Lab Standards

The testing laboratory should be independent from the manufacturer. Janoshik Analytical (Czech Republic) is the most widely referenced third-party lab in the peptide research community. They provide HPLC, mass spectrometry, and sterility testing with published results. Other reputable labs include Colmaric Analyticals (US) and Labolic (EU).

Red flags to watch for: COAs without a named lab, COAs with mismatched batch numbers, and suppliers who refuse to provide documentation.

The Peptide Research Landscape in 2026

The peptide research field is accelerating. Multiple GLP-1 receptor agonists are in late-stage clinical trials, oral peptide formulations are advancing, and the obesity drug pipeline is more competitive than at any point in pharmaceutical history.

• Obesity Drug Approval Tracker 2026 — Every major pipeline candidate and expected FDA action date.
• Pipeline Timeline 2026 — Phase-by-phase catalysts for all major compounds.
• Oral Obesity Drugs 2026 — Wegovy pill vs orforglipron vs VK2735.
• Best Obesity Drug 2026 — Data-driven compound ranking by efficacy.
• Peptide Trends UAE 2026 — Search volume, demand shifts, and market data.
• Raw Powder Sourcing Guide — What distributors need to know about supply chains.